Top Articles

Collection agencies - being the target of one can be an unpleasant experience. Nevertheless, that unpleasant experience

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

should never extend so far that you are being harassed, lied to, or having your privacy invaded. The Fair Debt Collect

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ion Practices Act, or FDCPA, is a law was designed to protect you from unfair and illegal practices by collection agenci

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

s and outlines the rules a collection agency must follow while attempting to collect debts. Here are some of the ways in

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

which the Fair Debt Practices Act protects you:

Collection agencies may only contact you during sensible working hours

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

and may not cause undue interruption at your place of work. This means that they cannot call you late at night and if

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

our employer asks that they not call you at work, they must stop. Furthermore, a collection agency can only contact frie

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

nds or relatives to ascertain your contact information and must never reveal to an outside party the nature of their bus

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

iness with you.

Collection agencies may not use harassing techniques to collect debts. They may not resort to cruelty,

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

abusiveness, use impolite language or otherwise engage in acts that would be considered unprofessional. They are also f

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

orbidden by law to lie or make false statements for the purposes of collecting a debt and must be clear about the amount

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

of a debt at the beginning of all communication. They must always correctly identify themselves to you and may not thr

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

aten you. If you have any questions, they should do their best to answer them in a professional manner. Always remembe

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

r that collection agencies are paid by their clients – the organizations on behalf of which they are collecting the debt

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

. This means that they should NEVER collect more than the amount which you owe to the company they are working for.

La

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

states that collection agencies help debtors to understand their rights in the collection process. If you feel that you

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

have not been informed of your rights, or that those rights have been violated, you should contact the authorities and

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

lodge a formal complaint against the agency in question. Be sure to document all of your conversations with them and ke

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

p a record of all correspondence to back up your claim of harassment. Knowing your rights in the case a collection agen

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

cy comes knocking is important, but making payments on time is by far the best solution to the collection agency problem

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/131266/toparticles-The-Fair-Debt-Collection-Practices-Act.html">The Fair Debt Collection Practices Act</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/131266/toparticles-The-Fair-Debt-Collection-Practices-Act.html]The Fair Debt Collection Practices Act[/url]

Business growth lies in the ability to share leads, referrals and recommendations. Unfortunately some people do not understand the difference in the quality of each action.

Time, time, time. Consider these numbers: the average executive spends 22 percent writing and reading memos, reports, letters. That equals eleven workweeks. And they are spending over 50 percent of their time either reading your communication or responding to it! So if you want the big cheese to read your report, make certain that your executive summary—written for that decision maker—sings. Here are the details.

In the old days it was sufficient to put a site up on the web and money would just find it. Well not anymore. With this sad truth in mind, let's take a moment to examine how you can find a profitable niche and how you can monetize it.

Tags

Links

Top Articles - The Fair Debt Collection Practices Act

Related Articles: